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Abstract
Background: Electrotherapy effectiveness at different doses has been demonstrated in preclinical and clinical studies;
however, several aspects that occur in the tumor growth kinetics before and after treatment have not yet been
revealed. Mathematical modeling is a useful instrument that can reveal some of these aspects. The aim of this paper is
to describe the complete growth kinetics of unperturbed and perturbed tumors through use of the modified Gompertz
equation in order to generate useful insight into the mechanisms that underpin this devastating disease.
Methods: The complete tumor growth kinetics for control and treated groups are obtained by interpolation and
extrapolation methods with different time steps, using experimental data of fibrosarcoma Sa-37. In the modified
Gompertz equation, a delay time is introduced to describe the tumor’s natural history before treatment. Different
graphical strategies are used in order to reveal new information in the complete kinetics of this tumor type.
Results: The first stage of complete tumor growth kinetics is highly non linear. The model, at this stage, shows
different aspects that agree with those reported theoretically and experimentally. Tumor reversibility and the
proportionality between regions before and after electrotherapy are demonstrated. In tumors that reach partial
remission, two antagonistic post-treatment processes are induced, whereas in complete remission, two unknown
antitumor mechanisms are induced.
Conclusion: The modified Gompertz equation is likely to lead to insights within cancer research. Such insights
hold promise for increasing our understanding of tumors as self-organizing systems and, the possible existence of
phase transitions in tumor growth kinetics, which, in turn, may have significant impacts both on cancer research
and on clinical practice.
Background
Tumors are complex biological systems, and, in spite of
great therapeutic advances, many of these still do not
respond to treatment and lead to death. Part of the
complexity of the problem is the sheer consequence of
the tumor size and its histogenic characteristics. The
cancer phenomenon continues to challenge oncologists.
The pace of progress has often been slow, in part
because of the time required to evaluate new therapies.
To reduce the time to approval, new paradigms for
assessing therapeutic efficacy are needed [1]. This
requires the intellectual energy of scientists working in
the field of mathematics and physics, collaborating clo-
sely with biologists and clinicians. This essentially
means that the heuristic experimental approach, which
is the traditional investigative method in the biological
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modeling approach [2].
Significant research has been done in the modeling of
tumors using theoretical models and computer simula-
tions in order to describe and predict various aspects of
tumor growth kinetics (TGK). Predicting tumor growth
is important in the planning and evaluation of screening
programs, clinical trials, and epidemiological studies, as
well as in the adequate selection of dose-response rela-
tionships regarding the proliferative potential of tumors
[2-5].
The biological behavior of a malignant tumor is highly
influenced by its growth rate, which is determined by
many intratumoral and micro-environmental factors.
The space-time permanent growth is probably the most
characteristic feature of a malignant tumor.
Further advancement in mathematical modeling of
TGK critically depends on a thorough testing of pro-
posed models against new data as they become available
with the development of experimental techniques [3-6].
Thus, it is apparent that theoretical mathematical mod-
els are needed to study cancer.
In electrotherapy (ET) with low-level direct electrical
current (DEC), mathematical modeling has not been
used. ET was revolutionary when first introduced and is
a promising surgical technique for destroying tumors. It
has been shown to be a very useful, alternative tool
against cancer. Preclinical and clinical studies have
shown that ET is simple, safe, effective, and, minimally
traumatic, with few side effects. It provides a method
for treating solid cancers that are conventionally inoper-
able, those that cannot be resected after thoracotomy,
and those that are not responsive to chemotherapy or
radiotherapy [7-10]. Similar results have been reported
by our research group [11-15].
Although preclinical and clinical studies have shown
that ET has a marked antitumor effect, it is not widely
used in clinical practice. The reason is that ET is not a
well-established therapy due to the lack of a standar-
dized method and unclear knowledge concerning the
mechanisms involved. As a result an optimal electrode
distribution has not been determined for ET, nor has
the dose-response relationship been established. For this
reason, we pay special attention to these two factors
[16,17].
Camué et al. [14] experimentally report that an
increase in DEC intensity increases its antitumor effec-
tiveness, and that Ehrlich and fibrosarcoma Sa-37
tumors have a DEC threshold for which their complete
remission is reached. These results have been theoreti-
cally corroborated through the use of a modified Gom-
pertz equation (MGE), which has a good prediction
capability to describe both unperturbed and DEC-
perturbed
TGK [17].
Many intrinsic processes that occur in both unper-
turbed and DEC-perturbed TGK are unknown. We
believe that the MGE can be used as a tool to reveal
some of these processes in order to improve DEC effec-
tiveness. The aim of this paper is to describe the
complete growth kinetics of unperturbed and DEC-
perturbed fibrosarcoma Sa-37 tumors through the MGE
in order to generate useful insights into the mechanisms
that underpin this devastating disease. In this study, we
analyze this model taking into account the experimental
data reported in [14] for fibrosarcoma Sa-37 tumor.
Also, we discuss the current limitations and potential
implications of this model for further TGK research. It
is important to note that the results reported in [14]
and [17] support this paper.
Methods
This study is approved by the Committees of Ethics of
the National Center of Electromagnetism Applied
(CNEA) and the Conrado Benitez Oncologic hospital,
Santiago de Cuba, Cuba.
Complete growth kinetics for unperturbed and DEC-
perturbed tumors
Our experiences in preclinical and clinical studies have
indicated that DEC-treated TGK is complex, with two
well-defined regions (REG-I and REG-II). REG-I
(defined before DEC treatment is performed) includes
the initial time of tumor cell inoculation (t = 0 days) up
to the moment that tumor is perturbed by a DEC sti-
mulus, which occurs when it reaches a volume Vo
(initial volume selected by the therapist). REG-II
(defined after DEC treatment is performed) includes the
time at which the tumor is perturbed by DEC stimulus
up to the end of the experiment.
In preclinical studies, the end of the experiment is
fixed by the researcher, whereas in clinical studies, it
can occur at multiple events: 1) the patient dies, 2) the
patient leaves the clinical trial, or 3) the patient is com-
pletely cured [9,10,15]. It is important to point out that
this REG-II is only reported in the field of ET in cancer
[9-15,18-21].
Electrochemical treatment
Once fibrosarcoma Sa-37 tumors have reached approxi-
mately Vo =0 . 5c m
3 in BALB/c mice, four platinum
electrodes are inserted into their bases and a single-shot
electrotherapy is supplied. Vo is reached 15 days after
viable tumor cells are inoculated in the dorsolateral
region of the animals. Four groups (one control group
and three treated groups), each consisting of ten mice,
were randomly formed: the control group (CG), a
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Page 2 of 14treated group with 36 C/cm
3 (18 C in 0.5 cm
3)a n d6 . 7
mA for 45 min (TG1), a treated group with 63 C/cm
3
(31.5 C in 0.5 cm
3) and 11.7 mA for 45 min (TG2), and
a treated group with 80 C/cm
3 (40.0 C in 0.5 cm
3)a n d
14.8 mA for 45 min (TG3). The experimental details are
discussed by Camué et al. [14].
Modified Gompertz equation
A feature of the MGE is that it is developed after the
experiments. It is implemented in order to fit the
experimental data corresponding to REG-II for the Ehr-
lich and fibrosarcoma Sa-37 TGK [17], given by
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All parameters involved are real and positive. V*(t’)
represents the tumor volume (TV) at time t’ after DEC
treatment. The parameter a (a >0 )i st h ei n t r i n s i c
growth rate of the tumor related to the initial mitosis
rate. The parameter b (b > 0) is the growth deceleration
factor related to the anti-angiogenic process. The para-
meter a* is the modified tumor growth rate due to DEC
action. i (i > 0) is the DEC intensity that flows through
the tumor by the application of an external electric field.
io (io > 0) is the polarization current (or electric current
distributed into the tumor by DEC action). The para-
meter g is the first-order exponential decay rate of the
net effect induced in the solid tumor after the DEC is
removed and its inverse is the decay constant (or decay
time) that characterizes the duration of such an effect.
a1 and a2 are dimensionless parameters that depend
only on the (i/io) ratio.
The results obtained from fitting the experimental
data for REG-II of fibrosarcoma Sa-37 TGK for CG,
TG1, TG2, and TG3 are shown in Table 1. The numeri-
cal information is obtained upon fitting the individual
tumor growth data and then fitting the data for each
experimental group. The mean values and standard
errors of these optimized parameters after fitting were
computed [17].
Interpolation of data corresponding to REG-II of
fibrosarcoma Sa-37 TGK
Interpolation of experimental data corresponding to
REG-II of fibrosarcoma Sa-37 TGK was developed.
From an experimental point of view, to perform such
as t u d y ,t h ei n f o r m a t i o ni nE Ti sr e p o r t e di nt e r m so f
a non equidistant time dependence of TV (V*(t’)v s .t ’
plot, named TV plot) spaced by one day or more. As
a result, the TGK details are not revealed. At the
experimental level, it is difficult to show the TGK for
a small time step like one day because such a study
would be cumbersome, expensive in resources, time-
consuming, and requiring excessive handling of ani-
mals, which is not permitted by the ethics code care
and use of Laboratory Animals Committee. For this
reason, we interpolated the experimental data corre-
sponding to REG-II for this tumor type using different
time steps, Δt (1, 1/3, 1/8, 1/24, and 1/48 days). In
this case, we take into account the mean values of
each parameter in the MGE for each experimental
group (Table 1).
Reconstruction of REG-I for fibrosarcoma Sa-37 TGK
In the ET framework, neither experimental nor theoreti-
cal reports have taken into account REG-I of TGK
which, for the former, can be very important for under-
standing the fibrosarcoma Sa-37 natural history before
DEC treatment and its future influence on therapeutic
effectiveness after DEC treatment. For this reason, we
reconstructed this first region using an extrapolation
method (to find unknown values for TV in points that
are outside the typical studied range) for each Δt. In
order to obtain the complete TGK for CG, we substitute
t’ with (t-τ) in Equation 1, keeping in mind the a, b, and
Vo parameters (Table 1) and the interpolated experi-
mental data for REG-II. In this case, τ is a time delay
Table 1 Mean ± standard error of the parameters
obtained from fitting the experimental data of the
growth curve of fibrosarcoma Sa-37 tumors using the
MGE
Groups* a (days
-1) b (days
-1) g (days
-1) io (mA)
CG 0.513 ± 0.009 0.262 ± 0.006 0.000 ± 0.000 0.000 ± 0.000
TG1 1.793 ± 0.028 0.142 ± 0.006 0.184 ± 0.003 4.342 ± 0.007
TG2 1.584 ± 0.030 0.076 ± 0.002 0.107 ± 0.001 4.342 ± 0.007
TG3 0.006 ± 0.001 0.207 ± 0.002 0.189 ± 0.016 1.080 ± 0.210
*CG: control group. TG1: treated group with electrical current of 6.7 mA. TG2:
treated group with 11.7 mA. TG3: treated group with 14.8 mA. Each
experimental group consisted of 10 mice [14,17], which are exposed for
45 minutes.
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Page 3 of 14that represents the time interval from the point at which
the tumor cells are inoculated in the host until the solid
tumor reaches Vo.
The considerations included in the MGE are:
1. For unperturbed tumors (a*=a for i =0 ) ,a in
Equation 1, is constant during TGK. In this case, the
MGE coincides with the conventional Gompertz equa-
tion [1,17,22,23].
2. REG-I for fibrosarcoma Sa-37 TGK is the same for
C G ,T G 1 ,T G 2 ,a n dT G 3 .A sar e s u l t ,a in Equation 1,
is the same for all of the experimental groups. This
assumption has been experimentally corroborated, since
the tumors in CG, TG1, TG2, and TG3 reach Vo at
approximately the same time τ (τ = 15 days) [14].
The MGE can be rewritten in the form
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w h e r eti st h et i m et h a te l a p s e sf r o mt h ei n i t i a l
moment at which tumor cells are inoculated in the host
(t = 0 days) up to the end of the experiment. t’ is the
time that elapses from the moment of DEC application
up to the end of the experiment.
Graphical strategies for the analysis of TGK of the
experimental groups
Different graphical strategies are used in order to obtain
further time-dependent information for both untreated
and DEC-treated TGK that is not revealed in a simple TV
plot. For this reason, we use the following plots: first deri-
vative of tumor volume (FDTV) versus t, named the
FDTV plot (or dV*(t)/dt vs. t plot); TV dependence of
FDTV, named FDTV-TV plot (or dV*(t)/dt vs. V*(t) plot),
the time consecutive dependence on TV plot, named CTV
plot (or V*(t) vs. V*(t-Δt) plot); and the modules and log-
log plots for TV and FDTV-TV in order to analyze
whether REG-I and REG-II for TG3 are the same.
I ti si m p o r t a n tt op o i n to u tt h a tt h er e s u l t ss h o w ni n
this paper are in long format (scaled fixed point with 15
digits after the decimal point).
Results
Analysis of complete unperturbed fibrosarcoma Sa-37
TGK
The complete growth kinetics of unperturbed fibrosar-
coma Sa-37 tumors are generated by interpolation of
the experimental data for REG-II and the extrapolation
process for REG-I using Equation 5 with values for a, b,
τ,a n dV o from the CG (Table 1). TGK exhibits a
characteristic S shape with three stages (SI, SII, and
SIII), which are well defined for all Δt values, as shown
in Figure 1 for Δt = 1/3 days.
The results show that SI is nonlinear and that there are
two intersection points that separate each of the stages.
The first point (Vs in Figure 1) is obtained from the inter-
ception between SI and SII, and it represents the begin-
ning of SII (TGK is triggered). The second point (Vic in
Figure 1) is obtained by the interception of SII and SIII,
representing the beginning of SIII (TV tends to a limit
value, Vf). Vic represents the irreversible TV from which
it growth up to Vf. The Vs,V ic,a n dV f points are charac-
terized by an ordered pair (t, TV) and are estimated as
(12.34 days, 0.069 cm
3), (25.99 days, 3.169 cm
3)a n d( 6 0
days, 3.536 cm
3) for all values of Δt, respectively.
The interpolation and extrapolation processes reveal
that unperturbed fibrosarcoma Sa-37 TGK has a point of
inflection, Vi at (17.56 days, 1.301 cm
3). This value may
also be analytically corroborated by making i = 0 and set-
ting the second derivative of Equation 1 to zero. Vi is a
p o i n ti nt h eT G Ka tw h i c ht h ec u r v a t u r ec h a n g e sf r o m
concave upwards (positive curvature) to concave down-
wards (negative curvature). Additionally, these processes
predict three other TV values, which are observed in the
experiment: Vo =0 . 5c m
3 at 15 days; 0.02 cm
3 at 11.29
days; and 0.03 cm
3 at 11.60 days [14]. In preclinical stu-
dies, our experience shows that 0.02 cm
3 is the smallest
measurable TV, designated as Vm [11-14]. Vm for fibro-
sarcoma Sa-37 tumors is experimentally observed at 12
days [14]. The difference in time is 0.71 days, which is
not significant from an experimental point of view.
We macroscopically observe the first non-zero
volume, Vob, for fibrosarcoma Sa-37 at 8 days (Figure
Figure 1 Time dependence of TV: Unperturbed fibrosarcoma
Sa-37 TGK (CG) for the parameters i = 0 mA, a = 0.513 days
-1,
b = 0.262 days
-1,V o = 0.5 cm
3 and a time step of Δt = 1/3
days.
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Page 4 of 141). This tumor size is observable and palpable, but not
measurable. Equation 5 estimates Vob to be 0.000016
cm
3 (0.031 cm in diameter) for this time value.
The FDTV-TV plot (Figure 2) shows that TV
increases between Vobs and Vf; however, FDTV increases
from Vs to Vi and then decreases to zero (from Vi to
Vf). Figure 2 illustrates that reaches its maximum value,
FDTVmax when TV reaches Vi.T h eo r d e r e dp a i r( V i,
FDTVmax) is (1.301 cm
3,0 . 3 4 1c m
3/day), which is
observed at 17.56 days.
Analysis of REG-II DEC-perturbed TGK for TG2
We directly present the results for REG-II TGK for
tumors treated with DEC for 45 minutes because the
REG-I is similar to that of the CG. The complete fibro-
sarcoma Sa-37 TGK treated with 11.7 mA (TG2) is
shown in Figure 3, for Δt = 1/3 days, in agreement with
other values of Δt = 1, 1/8, 1/24, and 1/48 days (results
not shown). This figure reveals that REG-II TGK (from
Vo up to end of the experiment) is characterized by two
sub-regions (REG-IIa and REG-IIb). In REG-IIa, TV
decreases from Vo to its minimum volume, Vmin,
whereas in REG-IIb, it increases from Vmin until the end
of the experiment. Additionally, Vmin is estimated by the
interception of REG-IIa and REG-IIb, resulting in a
value of 0.0698 cm
3 that is reached at 20.58 days, for all
Δt values, as shown in Figure 3, for Δt = 1/3 days. Vmin
is analytically corroborated through the following trans-
cendent equation, constructed by minimizing V*(t’)i n
Equation 1, given by
ae a ae a e e
tt t t
11 2 1 0   
   −− − − ++ () −+ () = (6)
For this, we substitute the values of a, b, g, i,a n dio
for TG2 (Table 1) in Equation 6. Vmin is experimentally
observed to be 0.07 cm
3, reached at 21 days after the
inoculation process. The differences between the esti-
mated and analytical values are 0.0002 cm
3 for TV and
0.42 days for time, neither of which are significant at
the experimental level.
Figure 4 shows that when TV decreases from Vo to
Vmin, FDTV first decreases from 0.5 to 0.376 cm
3 (posi-
tive slope) and then it increases from 0.376 to 0.069
cm
3 (negative slope). The FDTV values for 0.376 and
0.069 cm
3 are - 0.3069 cm
3/days (at 15.33 days) and
0.000068 cm
3/days (at 20.58 days), respectively. The
Figure 2 TV dependence of the FDTV: Unperturbed fibrosarcoma
Sa-37 TGK (CG) for the parameters i = 0 mA, a = 0.513 days
-1,
b = 0.262 days
-1,V o =0 . 5c m
3 and a time step of Δt = 1/3 days.
Figure 3 Time dependence of TV: DEC-perturbed fibrosarcoma
Sa-37 TGK (TG2) for the parameters i = 11.7 mA, a = 1.584
days
-1, b = 0.076 days
-1, g = 0.107 days
-1, io = 7.431 mA, and
Vo = 0.5 cm
3 and a time step of Δt = 1/3 days.
Figure 4 TV dependence of the FDTV: DEC-perturbed
fibrosarcoma Sa-37 TGK (TG2) for the parameters i = 11.7 mA,
a = 1.584 days
-1, b = 0.076 days
-1, g = 0.107 days
-1, io = 7.431
mA, and Vo = 0.5 cm
3 and a time step of Δt = 1/3 days.
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3/days corresponds to the mini-
mum negative value of FDTV, FDTVmin,w h i c hi s
observed at 15.33 days and between Vo and Vmin (Figure
4); however, this is not revealed in the TV plot (Figure 3).
The TV correspondent to FDTVmin in Figure 4, reveals
that when the TV reaches Vmin, it always increases from
Vmin up to Vf; however, FDTV increases from Vmin up to
Vi (predicted as (1.461 cm
3, 0.121 cm
3/days) and reached
at 42.22 days). Then, FDTV decreases to zero from Vi up
to Vf.
Analysis of REG-II DEC-perturbed TGK for TG3
A completely different picture is observed in REG-II of
the DEC-perturbed fibrosarcoma Sa-37 TGK for TG3,
as shown in Figure 5. This TGK is characterized by a
decrease of TV from Vo to 0 cm
3, with two well-defined
sub-regions (REG-IIc and REG-IId). In REG-IIc, TV
rapidly changes from Vo to TV from which begins its
complete destruction, named Vd (estimated as 0.014
cm
3 at 21.58 days); however, in REG-IId, it slowly varies
from Vd to zero, reached at 30 days after the inoculation
process (15 days after DEC treatment), as shown in Fig-
ure 5, for Δt = 1/3 days. These results are in agreement
with those obtained for the other values of Δt. This fig-
ure reveals that in REG-IIc, there is a point of inflection
Vid, which is predicted at (16.15 days, 0.355 cm
3).
Figure 6 reveals, that TV and FDTV decrease from Vo
to Vid (estimated as 0.355 cm
3, -0.163 cm
3/day) at 16.15
days (positive slope), and then both magnitudes decrease
up to a state of the tumor characterized by the ordered
pair (0.014 cm
3, - 0.0072 cm
3/day) at 21.58 days (nega-
tive slope). TV and FDTV abruptly decrease to zero for
TV smaller than Vd (negative slope).
We propose a CTV plot in order to demonstrate
whether the tumor can be completely reversible, as
shown in Figure 7. In this figure, a closed loop appears
for Δt = 1/3 and 1/24 days, being narrower for Δt=
1/24 days. This figure reveals that REG-I and REG-II for
fibrosarcoma Sa-37 TGK are not symmetric. In addition,
an analysis of the FDTV module versus TV plot (Figure 8)
and the log-log plot (log TV versus log t, log FDTV versus
l o gt ,a n dl o gV ( t )v e r s u sV ( t - Δt ) )a r ec o n d u c t e dt o
demonstrate whether REG-I and REG-II are proportional.
The figures indicate that these two regions are not
symmetrical or equal.
Eliminating the nonlinear part in both REG-I and
REG-II shown in Figure 8, we may fit each one of these
regions to a straight line. For REG-I, the slope ± its
Figure 5 Time dependence of TV: DEC-perturbed fibrosarcoma
Sa-37 TGK (TG3) for the parameters i = 14.8 mA, a = 0.006
days
-1, b = 0.207 days
-1, g = 0.189 days
-1, io = 1.080 mA, and
Vo = 0.5 cm
3 and a time step of Δt = 1/3 days.
Figure 6 TV dependence of the FDTV: DEC-perturbed
fibrosarcoma Sa-37 TGK (TG3) for the parameters i = 14.8 mA,
a = 0.006 days
-1, b = 0.207 days
-1, g = 0.189 days
-1, io = 1.080
mA, and Vo = 0.5 cm
3 and a time step of Δt = 1/3 days.
Figure 7 Time consecutive dependence of the TV plot (V*(t) vs.
V*(t-Δt) plot) for Δt = 1/3 and 1/24 days.
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Page 6 of 14error and the intercept ± its error are 0.724 ± 0.011 and
- 0.729 ± 0.024, respectively. These respective para-
meters are 0.992 ± 0.031 and - 0.524 ± 0.068, for REG-
II. The ratio between the slopes is 1.37.
In the CG, the CTV plot shows that V(t) increases
with increasing V(t-Δt), as expected. Additionally, the
CTV plot for TG2 reveals that both V(t) and V(t-Δt)
decrease to 0.376 cm
3 beyond Vo. Then, V(t) increases
with decreasing V(t-Δt) until reaching Vmin. Beyond this
value, both V(t) and V(t-Δt) increases.
The patterns shown in Figure 3 and Figure 4 for TG2
are similar to those for TG1. Furthermore, the results
obtained for fibrosarcoma Sa-37 TGK are similar to
those obtained for Ehrlich tumors in the three experi-
mental groups. For this reason, in the present study,
such results are not included.
Discussion
We show that the macroscopic behavior of both
untreated and DEC-treated fibrosarcoma Sa-37 TGK
can be realistically modeled using Equation 5. For this,
we use previous experimental data for CG, TG1, TG2,
and TG3 [14]; the parameters are obtained from fitting
these data (Table 1) [17], and both interpolation and
extrapolation methods for different time steps Δt (1; 1/
3; 1/8; 1/24; and 1/48 days) are used.
Unperturbed fibrosarcoma Sa-37 TGK
The TV plot corroborates that the complete untreated
fibrosarcoma Sa-37 TGK (i =0 )e x h i b i t sa nSs h a p e
with three well-defined stages (SI, SII, and SIII) (Figure
1). SI is common to each experimental group, and it is
associated with the establishment of the tumor in the
host. SII is related to rapid tumor growth. SIII of this
kinetic shows slow tumor growth and its behavior
towards Vf (asymptotic value).
In SI, Vob for fibrosarcoma Sa-37 tumor at 8 days is
experimentally observable and palpable but not measur-
able [14]; however, Equation 5 predicts this value. Ner-
terets et al. [24], reported tumor diameters below 0.025
cm via imaging with X-ray phase-contrast micro-CT in-
line holography. The extrapolation of SI estimates a
tumor size of 0.0000082 cm
3 to be reached at 7.79 days,
with the first approximation assumption that 0.025 cm
3
is the smallest volume measured for all tumor types.
The differences between these values and those esti-
mated for this tumor type are 0.0000078 cm
3 for TV
and 0.21 days for time, which are not significant at the
experimental level.
Experimentally, TV is measured with a vernier caliper
with a precision of 0.005 cm, and the thickness of the
mouse skin (between 0.1 and 0.2 cm) is taken into
account. Our experience indicates that above 0.02 cm
3,
the mouse skin thickness is negligible as compared with
the tumor size [11-14]. Below 0.02 cm
3, this thickness is
comparable and larger than the tumor size, being more
evident when the TV approaches Vob.
Equation 5 is continuous and smooth for all t (from t =
0 up to the end of the experiment), in contrast with the
experiment. The tumor sizes are smaller than 10
-6 cm
3,
below Vob, which cannot be observed or measured with
any of the current experimental techniques for measuring
TV, and therefore, to a first approximation, the sizes are
considered as zero, in agreement with our experimental
o b s e r v a t i o n s[ 1 1 - 1 4 ] .T h i ss u g g e s t st h a tR E G - Ic o n s i s t s
of two parts: from t = 0 up to tob (tob:o b s e r v a b l et i m e ,i n
days, for which Vob is observed) and from tob up to τ.A s
a result, Equation 5 can be rewritten as
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(7)
Equation 7 suggests that the MGE is continuous for
t ≥ tob. Our experience indicates that Vob and tob
depend on the tumor histogenic characteristics, the host
type, and the initial concentration of tumor cells inocu-
lated in the host [11-14].
We experimentally observe that fibrosarcoma Sa-37
solid tumors are spheroids between 8 and 10 days (SI of
TGK), which are also palpable and observable but not
measurable. Our model predicts that TV at 10 days is
0.0025 cm
3 (0.17 cm in diameter). It is surprising that
Figure 8 Analysis conducted by separating REG-I and REG-II in
a plot of module of FDTV versus TV.
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Page 7 of 14this volume range (0.031 to 0.17 cm in diameter) for
which the tumor is spherical coincides with that
reported by other authors for the avascular phase (0.025
up to 0.2 cm in diameter) [5,25-32]. Our model esti-
mates that a tumor 0.2 cm in diameter (0.0042 cm
3)i s
reached at 10.28 days. The differences for volume and
time are 0.0017 cm
3 and 0.28 days, which are not signif-
icant at the experimental level.
The fact that the tumors are spheroids (between
0.000016 and 0.0025 cm
3) may be explained by a central
force field of the Coulomb type due to the fact that the
cancer cells are negative charged [33]. It is important
keep in mind that a force field is central if and only if it
is spherically symmetric. An increase in the tumor cell
number occurs when the tumor grows, and as a result,
these cells are closer. Since they have the same electrical
charge, they are repelled and the tumor is deformed, a
fact that explains why the tumor has an ellipsoidal
shape after 10 days.
The results show that TGK for SII changes quickly at
first (from Vs up to Vi:c o n c a v eu p w a r d s )a n dt h e n
slowly (from Vi up to Vic: concave downwards). This
pattern occurs because FDTV first increases and then
decreases with increasing TV. In the first case (when
both TV and FDTV increase), several factors are
involved, such as local growth that is facilitated by
enzymes (e.g., proteases) that destroy adjacent tissues
and, tumor angiogenesis factors that are produced to
promote formation of the vascular supply required for
further tumor growth, among others [1]. In the second
case (when FDTV decreases with increasing TV), the
tumor itself generates different mechanisms that oppose
its own growth (i.e., anti-angiogenic substances). If the
tumor does not generate such mechanisms, its growth
would be exponential and, as a consequence, the tumor-
host relationship would be broken, which is not
observed in oncological practice [1]. This may indicate
that unperturbed tumors intelligently regulate their own
growth. This means that the tumor self-organizes, and
as a result, new emergent variables appear in order for
the tumor to grow, evade the immune system, and
achieve maximum survival.
The FDTV behavior may suggest that the tumor dou-
bling time and a are not constant during unperturbed
fibrosarcoma Sa-37 TGK, in agreement with Steel [22].
This result is in contrast with the fact that these two
kinetic parameters are constant during all TGK, as we
assume in this paper and as reported previously by our
group [17] and other authors [1,23]. Additionally, the
TV dependence of FDTV indicates that, Vi may have
important implications in DEC planning, if we take into
account the fact that the tumor is more sensitive to
DEC than healthy tissue [7-15,18-21], the Steel equation
[22], and the results of Smith et al. [34].
In SIII, the tumor behavior is explained by the fairly
slow rate of growth due to the amount of nutrients and
O2 needed for quick expansion of the tumor [1,22].
Both interpolation and extrapolation methods estimate
Vm,V s,V o,a n dV f with good accuracy as well as their
respective times, which are experimentally observed [14].
This is reasonable because the differences between the
experimental and theoretically predicted values for these
volumes and times at the experimental level are not
significant. Furthermore, these methods predict Vi and
Vic and their respective times, which are not available
from a TV plot. These points may have important impli-
cations in TGK and tumor treatment. The existence of
Vic establishes the irreversibility of TGK.
Our experience in preclinical studies indicates that a
good DEC effectiveness is obtained for TV smaller than
1.5 cm
3 [11,12,14]; however, it markedly decreases for
TV bigger than 1.5 cm
3 although DEC treatment is
repeated several times [13]. In clinical studies, DEC
effectiveness decreases when TV ≥ 8c m
3 [9,10,15]. It is
interesting that 1.5 cm
3 is near to Vi,f a c tt h a tm a ys u g -
gest that DEC treatment is effective for TV below Vi,
indicating that is important to know this TV in TGK. Vi
may be a criterion of application for this therapy. We
suggest to apply electrotherapy for TV below Vi.
DEC-treated fibrosarcoma Sa-37 TGK for TG2
In TG2, REG-IIa (from Vo up to Vmin) is related to the
rapid tumor inhibition resulting from DEC cytotoxic
action, and REG-IIb (from Vmin up to Vf) represents the
tumor prevalence (tumor re-growth). However, FDTV-
TV plot reveals that FDTV first decreases up to
FDTVmin and then increases with decreasing TV in
REG-IIa. This may suggest that in this region the tumor
self-organizes whereas its volume decreases, indicating
that DEC dose is not effective, an aspect not addressed
in the literature. As a result, FDTV tends to 0.000068
cm
3/days corresponding to Vmin,f r o mw h i c hT G K
triggers.
Tumor destruction (when both TV and FDTV
decrease) is caused by DEC cytotoxic action, which
induces toxic products in the tumor, generated by elec-
trochemical reactions [19], and it potentiates humoral
and cellular components of the immune system [20]. At
this time interval, necrosis, apoptosis, chronic inflamma-
tion, polymorphous nuclear, monocytes, vascular con-
gestion, and the activation of macrophages and T
lymphocytes have been observed [7-15,18-21].
Tumor self-organization is not observed in the TV
plot and occurs when FDTV changes of slope indepen-
dently of the decrease of TV. This timing may occur
because the DEC dose used does not induce significant
damage to the tumor. As a result, the tumor potentiates
its existing mechanisms and/or generates other new
Cabrales et al. BMC Cancer 2010, 10:589
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Page 8 of 14mechanisms for its own protection, growth, and metas-
tasis processes in order to reach its maximum survival.
This second process can also be explained from the
point of view of the complexity theory because the
tumor is self-organized and new emergent variables
appear [35-38]. This self-organization process of the
tumor dominates the process of tumor destruction
caused by DEC action, with TV reaching Vmin and con-
sequential tumor re-growth (REG-IIb).
Vmin observed in the TV plot for TG2 is very impor-
tant from a therapeutic point of view because when TV
reaches this value, DEC should be repeated [9,10,13];
however, the results shown in this study indicate that
the tumor is self-organized when it reaches Vmin.F o r
us, the existence of FDTVmin (corresponding to TV =
0.376 cm
3) on the FDTV-TV plot is surprising because
this tumor self-organization process is not observed in
the TV plot and therefore its explanation is not possible
from this plot. This is relevant, at the therapeutic level
because DEC stimulus alone or combined should be
repeated when the TV reaches this value.
This procedure may be implemented in practice
through two possible ways: 1) by weekly measuring
(once or twice) the TV during the first three months
after DEC treatment by means of a vernier caliper (for
superficial tumors) or ultrasound (for visceral tumors)
and 2) by knowing the tumor relaxation time (Trt)o fa
small sample treated with DEC by means of Nuclear
Magnetic Resonance method.
In the first way, we observe a significant decrease of TV
in DEC treated patients during the first three months,
after this time, a tumor re-growth is observed if the dose
is not effective [15]. We suggest two measurements/week
of TV to obtain various experimental points in the first
three months of observation so that the values of the
parameters: a, b, g,a n dio can be calculated knowing the
values of Vo a n dT Vo nt h ef i r s tf o u rm e a s u r e m e n t s .
Then, a numerical method is used to solve a non-homo-
geneous system of four non-linear equations with these
four unknown parameters. This is possible because MGE
has a good prediction capability to describe both unper-
turbed and perturbed tumor growths [17]. We can pre-
dict the temporal behavior of TV (TV plot) and of its
derived (FDTV plot) once the values of these four para-
meters are well-known and then estimate FDTVmin in a
FDTV-TV plot. If FDTV changes the sign of its slope
(positive to negative) although TV continues increasing,
we suggest to repeat this therapy and/or to combine it
with another therapeutic procedure, as shown in this
study. Therefore, we do not recommend the use Tomo-
graphy Axial Computerized and Imaging Nuclear Mag-
netic Resonance, because of their high costs and the
regulatory norms established for the use of each one of
these imaging techniques.
In the second way, the knowledge of Trt is important
because we know the time for which the tumor recovers
after DEC treatment, and the times that DEC treatment
should be repeated in order to the tumor is not self-or-
ganize (for example, at a time smaller than Trt). The
knowledge concerning to these two facts will allow us to
determine the exact time at which the DEC should be
repeated, and as a result, it will allowed one to avoid
unnecessary DEC stimulus to the patient. The tumor
self-organization process is slower if the duration of the
DEC cytotoxic effect induced into the tumor is greater
than Trt. In a previous study, we corroborate theoreti-
cally that DEC effectiveness increases with the increase
of the duration of DEC cytotoxic effect induced into the
tumor [17]. The introduction of any of these two possi-
ble ways in our experiments will lead to a high antitu-
mor effectiveness, which suggests that our future
researchers should take this fact into account.
DEC-treated fibrosarcoma Sa-37 TGK for TG3
In TG3, REG-IIc (when TV and FDTV both rapidly
decrease) may be explained from a biological point of
view by DEC cytotoxic action, as we propose above. It
s h o u l db en o t e dt h a ti nt h eF D T V - T Vp l o t ,j u s tb e f o r e
the tumor reaches Vd, there is a change of slope for
FDTV with Vid, implicating that other antitumor
mechanisms have been activated (e.g., the activation of
cellular and humoral components of the immune system
mentioned above and others unreported until now). In
contrast to TG2, in TG3, this change of slope for FDTV
does not change its negative sign between Vo and Vd.
The net rate of the antitumor processes involved
between Vo and Vid is higher than that resulting from
other antitumor processes induced between Vid and Vd.
From a biophysical point of view, this indicates the exis-
tence of at least two other unknown main antitumor
mechanisms, which can occur simultaneously. Each one
of these mechanisms has its own time constant, in
agreement with previous reports [11]. As a result of
these antitumor mechanisms, the tumor is completely
destroyed (or reversible). This is corroborated, as TV
and FDTV tend to zero when TV is smaller than Vd;i n
agreement with our results [17].
The fact that the complete TGK for TG3 is a closed
loop suggests the reversibility of the tumor. We believe
that this is true if TV is comprehended between Vm and
Vi. This fact corroborates the above discussion regarding
the goal of Vid in DEC treatment. Some additional
experiments are required to prove this statement.
This loop shows that REG-I of TGK (before DEC
treatment) and REG-II (after DEC treatment) are asym-
metric for all Δt values. The linear fits of these two
regions suggest that the slope of the curve for REG-II is
1.37 times higher than that for REG-I, a fact that
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to the rate of growth, in agreement with the Norton-
Simon hypothesis [39]. Prior to this study, we think that
these rates are equal.
This new paradigm forces us to reconsider our knowl-
edge and to modify our traditional approach to research
and treatment. This statement is relevant for ET
because it completely changes the conception of cancer
treatment. The actual idea behind in vitro and in vivo
studies is to treat the tumor and then to observe its evo-
lution, which is not known to priori [7-15,18-21]. How-
ever, the existence of Vd establishes that fibrosarcoma
Sa-37 tumors have a DEC threshold for which the
tumor is completely destroyed, as demonstrated experi-
mentally and theoretically for Ehrlich and fibrosarcoma
Sa-37 tumors [14,17], in agreement with other studies
[9,10,18,21,33]. This is possible if we establish an explicit
dependence of Vd as a function of the parameters of
Equation 7, the host type, and the ET parameters
(dosage and exposure time of DEC, electrode array, and
times that DEC is repeated). This is very complex at the
experimental and theoretical levels; however, mathema-
tical modeling may be a useful tool for finding an
approximate solution (analytical or numerical) to this
problem. Such modeling will lead to further improve-
ment in the treatment of solid tumors, and it can also
help guide treatment decisions for therapists treating
patients (or animals) with this disease. In addition, this
statement will contribute to standardizing this therapy.
New predictions and hypothesis for TGK
In the physical sciences, mathematical theory and
experimental investigation have always worked together.
Mathematical theory can help to direct experimental
research, while the results of experiments help to refine
t h em o d e l i n g[ 2 ] .T h i si sp r e c i s e l yo n eo ft h ei n t e n t i o n s
of this manuscript.
Although Equation 5 (or 7) does not reveal other
information, we can propose hypothesis-testing (or
hypothesis-generating) methods from it and our experi-
mental observations. The fact that in REG-I of TGK,
specifically in SI, for all experimental groups, Ehrlich
and fibrosarcoma Sa-37 solid tumors are not observed
below Vob (tumor cells in suspension) and are observed
above Vob (solid tumor or tumor mass) may suggest the
existence of a phase transition. It is more evident for
these tumor types in REG-II of TGK for TG3 when the
solid tumor passes from its active phase (below Vd)t o
the phase in which the tumor is completely destroyed
due to DEC action (above Vd) [14]. In both cases, these
transitions are named PT1 and PT2, respectively, as
schematically represented in Figure 9 and Figure 10.
This is also supported if we remember that a phase
transition has the characteristic of taking a medium
with given properties and transforming some (or all) of
it into a new medium with new properties (i.e., the
transformation of a thermodynamic system from one
phase to another) [40,41].
We know from thermodynamics that at the phase tran-
sition point, physical properties may undergo abrupt
changes: for instance, the volumes of the two phases may
be vastly different, as observed in SI (below and after Vob)
and REG-II in TG3 (below after Vd), a fact that could sug-
gest the existence of a critical TV in SI, Vc1, and another
in REG-II in TG3, Vc2, as schematically represented in Fig-
ure 9 and Figure 10. We believe that when Vc1 (Vc2)i s
reached; the tumor begins to grow (completely destroyed).
It is possible that such a phase transition involves a
large amount of energy (a dissipative system) accompa-
nied by fluctuations, chaos, and/or self-organization pro-
cesses with the presence of emergent variables, in
agreement with other authors [5,35-38,40-46].
Several authors have reported various phenomena
that occur in SI of TGK, such as: a transition from
the tumor avascular phase to the vascular phase (angio-
genesis), which is accompanied by fluctuations
[5,25-28,31,32]; the existence of a stochastic transition at
the change between these two tumor phases [29]; the
disruption of normal blood vessels of the organs in
which the tumor is developing caused by chaotic growth
[25]; the existence of a threshold under which sprouts
cannot reach the tumor during the growth of the vascu-
lar network [46]; among others. It is interesting that our
model reveals that SI is highly non linear, a fact that
could be associated with the presence of chaos [5,42,43],
in agreement with other authors [5,42,43]. This corre-
sponds with established non-equilibrium thermody-
namics, in which systems driven out of equilibrium (as
Figure 9 Schematic representation of TGK.
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exhibit fluctuations or phase transitions [35,44]. In addi-
tion, these systems can develop from disorder (systems
known as dissipative) because they are formed and
maintained by dissipative processes that take place due
to an exchange of energy and matter between the sys-
tem and its environment, and they disappear if that
exchange ceases. From Equation 1 (5 or 6), it may be
corroborated that a tumor is a dissipative system
because io is much lower than i [17]. The biological pro-
cesses that are constantly receiving, transforming, and
dissipating chemical energy can, and do, exhibit proper-
ties of self-organization far from thermodynamic equili-
brium [35-38,44,45].
MGE offers information of the global dynamics of
unperturbed and DEC treated tumors and therefore only
gives a limited understanding about the self-organization
processes in TGK. However, we believe that these pro-
cesses are involved in unperturbed and DEC treated
TGK for discussed above and the following facts, which
are implicitly in MGE: 1) Self-organization makes sense
only in relation to the whole: it is the whole that self-
organizes into a multitude of interacting levels. At the
same time, the whole cannot sustain its integrity, if the
process of self-organization does not work. This suggests
that self-organization has an important role in the forma-
tion, maintenance, and function of cells, tissues, organs
and the complete human body. 2) A key requirement for
a self-organizing system is nonlinearity and therefore the
self-organizing systems are governed by nonlinear
dynamics [47], in agreement with our results. 3) Gom-
pertzian dynamics emerges as a result of the fractal-sto-
chastic dualism, which is a universal natural law of
biological complexity [48], in agreement with Brú et al.
[49]. 3) System changes from non-order to order, from
low-grade order to advanced order, basis on the principle
of auto-organization adaption [50]. 4) Cancer is a reflec-
tion of a failing system; preventive steps should involve
rebalancing the entire system through lowering of disor-
derly complexity, entropy, and optimizing self-organiza-
t i o nw i t ho r d e r l yc o m p l e x i t y[ 5 1 ] .5 )T h em a l i g n a n t
tumor is a complex system and therefore this complexity
expresses its functionality and reflects a high degree of
resilience and robustness to environmental challenges
through their self-adaptation and internal self-organiza-
tion [51]. 6) The process of tumor cell growth, invasion
and metastasis involves a self-organized cascade of multi-
ple tumor-host and tumor-immune interactions [52].
Self-organization might be a general principle in cellular
organization and an elegant, efficient way to optimally
organize cellular structures [53]. 7) Self-organization
occurs when a real system evolves toward a higher differ-
entiation from its initial state (or pre-system phase) [51].
These two phases are revealed with MGE: pre-tumor
phase (below Vob) and solid tumor phase (above Vob).
Also, this differentiation is observed in our pathological
studies [11-15], and it is the cause of the aggressiveness
and difference in the cellular/molecular patterns of the
different types of malignant tumors [1]. In spite of these
facts and others, more studies at cellular/molecular/
atomic/quantum levels and new physic-mathematical
approaches are needed to have more meaningful results
about the self-organization process in TGK.
During such a phase transition, a tumor either absorbs
or releases a fixed (and typically large) amount of
energy, which is characteristic of a first-order phase
transition. Because energy cannot be instantaneously
transferred between the tumor and it’s surrounding
Figure 10 Representation equivalent of TGK from a biophysical point of view.
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“mixed-phase regimes” in which some parts of the sys-
tem have completed the transition and others have not.
Based on statistical physics, mixed-phase systems are
difficult to study, because their dynamics are violent and
challenging to control [40].
The hypotheses proposed in this study can doubtlessly
be seriously attacked by many; however, this study sets
the basis to derive some practical understanding from
our diverse (and often, at this time, empirical) experi-
mental and clinical observations in cancer electrother-
apy. The availability of powerful computers has already
helped to bridge the gap between observations and pre-
dictions in many complex problems, and a few attempts
have already been made to attack the problem of tumor
growth with mathematical models.
We are recognizing biophysics principles that may be
broadly applied in developing more useful programs of
DEC treatment of solid tumors. To begin to understand
the complexity of the proposed system, novel simulations
must be developed, incorporating concepts from many
scientific areas such as cancer research, statistical
mechanics, applied mathematics, and nonlinear dynami-
cal systems.
Our results suggest that the MGE should be modified,
or a new mathematical approach should be proposed in
order to describe TGK and explain the presence of at least
one of these phenomena. These results are, in agreement
with Bellomo et al. [2], who proposed that “future research
will definitely refine and improve the existing models,
while the analysis of the inherent mathematical problems
will hopefully lead to new mathematics, allowing us to
tackle problems presently beyond our technical abilities”.
Conclusion
In conclusion, the modified Gompertz equation is likely
to lead to insights within cancer research. Such insights
hold promise for increasing our understanding of
tumors as self-organizing systems and, the possible exis-
tence of phase transitions in tumor growth kinetics,
which, in turn, may have a significant impact both on
cancer research and on clinical practice.
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